A Framework to Guide the Optimal Development and Use of Real-World Evidence for Drug Coverage and Formulary Decisions

Journal of Comparative Effectiveness Research - United Kingdom
doi 10.2217/cer-2018-0059
Full Text
Abstract

Available in full text

Categories
Health Policy
Date
Authors
Publisher

Future Medicine Ltd

Related search

Real-World Evidence to Guide the Approval and Use of New Treatments

NAM Perspectives
2016English

Report on the Current Status of the Use of Real‐world Data (RWD) and Real‐world Evidence (RWE) in Drug Development and Regulation

British Journal of Clinical Pharmacology
Pharmacology
2019English

Pcp53 - A Diagnostic Framework to Evaluate Real-World Data Sources for Real-World Evidence Generation

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

A Structured Pre‐ and Post‐Approval Comparative Study Design Framework to Generate Valid and Transparent Real‐World Evidence for Regulatory Decisions

Clinical Pharmacology and Therapeutics
Pharmacology
2019English

The Microtomist's Formulary and Guide

American Journal of Public Health and the Nations Health
1955English

National Drug Policies to Local Formulary Decisions in Thailand, China, and Australia: Drug Listing Changes and Opportunities

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2012English

From Phase Ii Studies to Hta Submissions: Optimal Use of Evidence for Informed Decisions

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

Medicare Formulary Coverage and Restrictions for Opioid Potentiators From 2013 to 2017

Journal of General Internal Medicine
Internal Medicine
2019English

Correction: A Standardised Framework to Identify Optimal Animal Models for Efficacy Assessment in Drug Development

PLoS ONE
Multidisciplinary
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy